Related Experiment Video
Updated: May 13, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Vaccines against advanced melanoma
Tatiana Blanchard1, Pramod K Srivastava, Fei Duan
1Department of Immunology, and Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, CT 06030-1601, USA.
Clinics in Dermatology
|February 27, 2013
Summary
Cancer immune recognition doesn't always eliminate tumors. Identifying cancer-specific mutations is key for effective cancer antigen immunotherapy.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- The immune system recognizes cancer, but tumor elimination is not guaranteed.
- Quantifying immune system efficacy against tumors is challenging due to unknown encounter numbers.
- Tumor recognition implies the presence of tumor antigens, the specific targets.
Purpose of the Study:
- To review molecular identities of various tumor antigens.
- To discuss the application of these antigens in experimental melanoma immunotherapy.
- To critically evaluate past immunotherapy approaches for insights.
Main Methods:
- Review of molecular classifications of tumor antigens (mutation-specific, cancer-testis, differentiation, overexpressed).
- Analysis of experimental immunotherapy trials in mouse and human melanoma.
- Critical assessment of vaccine therapy strategies.
Main Results:
- Experimental immunotherapies using various tumor antigens have been largely unsuccessful.
- Despite failures, past approaches have yielded significant insights into melanoma immunology.
- Cancer-specific mutations represent the sole source of truly cancer-specific antigens.
Conclusions:
- Individual cancer-specific mutations are the most promising targets for cancer immunotherapy.
- Understanding tumor antigens is crucial for developing effective cancer treatments.
- Future immunotherapy strategies should focus on leveraging cancer-specific antigens.
More Related Videos
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...